Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Open-Label Extension Study of Idebenone in Duchenne Muscular Dystrophy
2007-007752-34Phase 2Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of idebenone in Duchenne muscular dystrophy (DMD), sponsored by Santhera Pharmaceuticals. Primary endpoint: Safety and tolerability of idebenone. Started Jun 2008; status: completed.
02
Drugs
idebenone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2007-007752-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007752-34.